Anlotinib Not Yet Recruiting Phase 2 Trials for Soft Tissue Sarcoma (STS) Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03792542Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive Chemotherapy
NCT04172805Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue Sarcoma